{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01840540",
      "OrgStudyIdInfo": {
        "OrgStudyId": "12-009298"
      },
      "Organization": {
        "OrgFullName": "Mayo Clinic",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "MSC for Occlusive Disease of the Kidney",
      "OfficialTitle": "Phase I Study of Autologous Mesenchymal Stem Cells in the Treatment of Atherosclerotic Renal Artery Stenosis"
    },
    "StatusModule": {
      "StatusVerifiedDate": "August 2017",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "April 2013"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "March 2014",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "April 2017",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "April 23, 2013",
      "StudyFirstSubmitQCDate": "April 23, 2013",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "April 25, 2013",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "August 4, 2017",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "August 7, 2017",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Stephen C. Textor, M.D.",
        "ResponsiblePartyInvestigatorTitle": "PI",
        "ResponsiblePartyInvestigatorAffiliation": "Mayo Clinic"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Mayo Clinic",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "To determine the safety and toxicity of intra-arterial infused autologous adipose derived mesenchymal stromal (stem) cells in patients with vascular occlusive disease of the kidney.",
      "DetailedDescription": "Individuals with unilateral arterial occlusive disease will be treated to injured kidney with autologous cells."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Atherosclerotic Renal Artery Stenosis",
          "Ischemic Nephropathy",
          "Renovascular Hypertension"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "renal artery stenosis",
          "renovascular hypertension",
          "ischemic nephropathy",
          "chronic kidney disease"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "6",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "infusion of autologous mesenchymal stem cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Patients will undergo a subcutaneous fat biopsy for expansion of mesenchymal stromal (stem) cells (MSC) in the Human Cell Therapy Laboratory. Patients will be admitted to the inpatient Clinical Research Unit of the Mayo Clinic Center for 3 days prior to treatment, for pre-infusion tests. Renal angiography will be performed to deliver a single intra-arterial dose of MSC's into one affected kidney. Patients will be observed for 24 hours for acute adverse events. Patients will have remote visits at 1 week, 4 weeks,8 weeks, and 6 months. At 3 months, patients will return for repeat evaluation of kidney function, blood flow and structural alterations within the clinical research unit at St. Mary's Hospital, Rochester, Minnesota. Thereafter, health assessment and blood draws will be repeated at 12 and 24 months with urinary cytology and MRI.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Arterial infusion of autologous mesenchymal stem cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Drug",
            "InterventionName": "Arterial infusion of autologous mesenchymal stem cells",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "infusion of autologous mesenchymal stem cells"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "MSC"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Renal blood flow and function in the treated kidneys.",
            "PrimaryOutcomeDescription": "Individual kidney blood flow, measured by multidetector CT contrast transit times, will be measured before and after MSC infusion.",
            "PrimaryOutcomeTimeFrame": "2 years"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Level of kidney function.",
            "SecondaryOutcomeDescription": "Level of kidney function will be assessed as glomerular filtration rate by iothalamate clearance. Tissue oxygenation within each kidney will be measured by Blood Oxygen Level Dependent (BOLD) magnetic resonance.",
            "SecondaryOutcomeTimeFrame": "2 years"
          }
        ]
      },
      "OtherOutcomeList": {
        "OtherOutcome": [
          {
            "OtherOutcomeMeasure": "Blood pressure levels.",
            "OtherOutcomeDescription": "Blood pressure will be assessed by oscillometric measurement.",
            "OtherOutcomeTimeFrame": "2 years"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "4.1 Inclusion Criteria\n\nAre between ages 40 and 80 years old.\nAdvanced vascular occlusive disease (atherosclerosis) affecting one or both kidneys: defined as a) loss of parenchymal volume and renal blood flow (measured by MDCT as previously described (17) and/or duplex ultrasound velocity above 300 cm/sec to the affected kidney to be infused with MSC's.\nHave serum creatinine below 2.5 mg/dL\nHave no-contraindications to angiography: severe contrast allergy\nHave no contraindications to MR evaluations: e.g. pacemaker or magnetically active metal fragments, claustrophobia\nAbility to comply with protocol\nCompetent and able to provide written informed consent\n\n4.2 Exclusion Criteria\n\nAdvanced CKD: Stage 5 (two kidney eGFR < 15 ml/min/1.73 m2) contralateral renal artery occlusion/stenosis above 75% or ESRD requiring dialysis\nClinically significant abnormalities on laboratory examination, including Bilirubin (> 2 x normal), platelets (<100 thousand), potassium (>5.5 mEq/L), and sodium (<130 mEq/L), ALT or AST more than 2 x normal, Prothrombin time (INR>1.4), Hemoglobin <10.0 g/dL.\nClinically significant medical conditions within the six months before administration of MSCs: e.g. myocardial infarction, active angina, congestive heart failure) that would, in the opinion of the investigators, compromise the safety of the patient.\n\nSpecific exclusions:\n\nClinical history of deep vein thrombosis within three months of MSC administration\nUncontrolled hypertension (Systolic BP >180 mmHg despite therapy)\nActive infection\nReduced ejection fraction (below 30%)\nEvidence of hepatitis B,C, or HIV\nDiabetes treated with insulin and/or glucose lowering agents\nAnemia (Hgb<10 g/dL)\nRegular use of potentially renotoxic drugs, e.g. non-steroidal anti-inflammatory agents (NSAID's): (>2 x weekly)\nHistory of cancer including melanoma (with the exception of localized skin cancers)\nInvestigational drug exposure within thirty (30) days of baseline\nBeck's depression score above 16\nPregnant or breast feeding.\nHistory of clinically significant auto-immunity or any previous example of fat-directed autoimmunity",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "40 Years",
      "MaximumAge": "80 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Stephen Textor, MD",
            "OverallOfficialAffiliation": "Mayo Clinic",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Mayo Clinic in Rochester",
            "LocationCity": "Rochester",
            "LocationState": "Minnesota",
            "LocationZip": "55905",
            "LocationCountry": "United States"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "27515308",
            "ReferenceType": "derived",
            "ReferenceCitation": "Camilleri ET, Gustafson MP, Dudakovic A, Riester SM, Garces CG, Paradise CR, Takai H, Karperien M, Cool S, Sampen HJ, Larson AN, Qu W, Smith J, Dietz AB, van Wijnen AJ. Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production. Stem Cell Res Ther. 2016 Aug 11;7(1):107. doi: 10.1186/s13287-016-0370-8."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000007674",
            "ConditionMeshTerm": "Kidney Diseases"
          },
          {
            "ConditionMeshId": "D000012078",
            "ConditionMeshTerm": "Renal Artery Obstruction"
          },
          {
            "ConditionMeshId": "D000006978",
            "ConditionMeshTerm": "Hypertension, Renovascular"
          },
          {
            "ConditionMeshId": "D000006973",
            "ConditionMeshTerm": "Hypertension"
          },
          {
            "ConditionMeshId": "D000003251",
            "ConditionMeshTerm": "Constriction, Pathologic"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000014652",
            "ConditionAncestorTerm": "Vascular Diseases"
          },
          {
            "ConditionAncestorId": "D000002318",
            "ConditionAncestorTerm": "Cardiovascular Diseases"
          },
          {
            "ConditionAncestorId": "D000020763",
            "ConditionAncestorTerm": "Pathological Conditions, Anatomical"
          },
          {
            "ConditionAncestorId": "D000014570",
            "ConditionAncestorTerm": "Urologic Diseases"
          },
          {
            "ConditionAncestorId": "D000001157",
            "ConditionAncestorTerm": "Arterial Occlusive Diseases"
          },
          {
            "ConditionAncestorId": "D000006977",
            "ConditionAncestorTerm": "Hypertension, Renal"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M5627",
            "ConditionBrowseLeafName": "Constriction, Pathologic",
            "ConditionBrowseLeafAsFound": "Stenosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9695",
            "ConditionBrowseLeafName": "Ischemia",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9176",
            "ConditionBrowseLeafName": "Hypertension",
            "ConditionBrowseLeafAsFound": "Hypertension",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9850",
            "ConditionBrowseLeafName": "Kidney Diseases",
            "ConditionBrowseLeafAsFound": "Nephropathy",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9181",
            "ConditionBrowseLeafName": "Hypertension, Renovascular",
            "ConditionBrowseLeafAsFound": "Renovascular Hypertension",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14071",
            "ConditionBrowseLeafName": "Renal Artery Obstruction",
            "ConditionBrowseLeafAsFound": "Renal Artery Stenosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M16552",
            "ConditionBrowseLeafName": "Vascular Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M21672",
            "ConditionBrowseLeafName": "Pathological Conditions, Anatomical",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16471",
            "ConditionBrowseLeafName": "Urologic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3617",
            "ConditionBrowseLeafName": "Arterial Occlusive Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9180",
            "ConditionBrowseLeafName": "Hypertension, Renal",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BXS",
            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
          }
        ]
      }
    }
  }
}